S&P raises EssilorLuxottica rating to A+ for EssilorLuxottica stock

Published on 10/27/2026 at 15:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EssilorLuxottica earns an A+ rating with stable outlook on October 23, 2026. EssilorLuxottica stock costs EUR 179.35 on October 27, 2026.

EssilorLuxottica earns a stronger credit assessment

The long-term credit rating rose from A to A+ with a stable outlook on October 23, 2026.
Third-quarter revenue reached EUR 7,486 million, up 7.20 percent at constant exchange rates.
The stock was trading at EUR 179.35 at Lang & Schwarz on October 27, 2026 at 3:11 p.m. CET.

EssilorLuxottica S.A., FR0000121667, Illustration mit AI erstellt.

EssilorLuxottica (ISIN FR0000121667) received an upgrade of its long-term credit rating to A+ from A on October 23, 2026, with a stable outlook, according to the EssilorLuxottica. The stock was trading at EUR 179.35 at Lang & Schwarz on October 27, 2026 at 3:11 p.m. CET.

Credit strength moves beyond eyewear

The upgrade changes the analytical framing for the group because S&P Global Ratings links the stronger assessment to EssilorLuxottica's shift from a consumer-focused business toward integrated medtech. The agency raised the issuer and senior unsecured debt ratings from A to A+, affirmed the short-term A-1 rating and kept the outlook stable, as stated in the S&P Global Ratings report dated October 23, 2026.

S&P forecasts free operating cash flow before leases of EUR 4.30 billion to EUR 4.80 billion annually from 2026 through 2028 and adjusted leverage between 1.50 times and 2.00 times. That combination gives the rating action a financial basis rather than making it only a strategic endorsement.

Revenue keeps the case concrete

EssilorLuxottica's third-quarter 2026 revenue reached EUR 7,486 million, up 9.00 percent at current exchange rates and 7.20 percent at constant exchange rates from the third quarter of 2025, according to the company's third-quarter release dated October 20, 2026. Revenue for the first nine months reached EUR 22,304 million, up 8.90 percent at constant exchange rates.

The mix also supports the rating narrative. Direct-to-consumer revenue rose 10.60 percent in the third quarter at constant exchange rates, while professional solutions increased 3.40 percent and the myopia management portfolio grew 24.00 percent.

Paris listing anchors the market view

Euronext identifies EssilorLuxottica as an ordinary share listed on Euronext Paris in EUR and included in the CAC 40. The new credit assessment and the revenue figures together point to a business whose defensive healthcare exposure is becoming more important to its investment story than its consumer image alone.

Stock price on October 27

EssilorLuxottica was trading at EUR 179.35 at Lang & Schwarz on October 27, 2026 at 3:11 p.m. CET. The further course of trading is shown by the continuously updated real-time quote of EssilorLuxottica stock.